CAPR CIK: 1133869

Capricor Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
36.4
FY22:
42.9
FY23:
50.9
FY24:
163
FY25:
323
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.89
FY22:
7.21
FY23:
7.88
FY24:
7.10
FY25:
33.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
41.3
FY22:
50.1
FY23:
58.7
FY24:
170
FY25:
356

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.13
FY22:
23.6
FY23:
31.3
FY24:
21.0
FY25:
35.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.83
FY22:
14.7
FY23:
4.86
FY24:
3.99
FY25:
14.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
31.4
FY22:
11.8
FY23:
22.6
FY24:
145
FY25:
306
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
41.3
FY22:
50.1
FY23:
58.7
FY24:
170
FY25:
356

All amounts in millions USD Data sources:SEC EDGARTwelve Data